Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-users

BACKGROUND: Exertional dyspnea is a hallmark symptom of fibrosing interstitial lung disease (fILD), and oxygen (O(2)) desaturation is common among patients with fILD. Supplemental O(2) is prescribed to maintain normoxia and alleviate dyspnea. We sought to better understand the associations between O...

Full description

Saved in:
Bibliographic Details
Published in:Multidiscip Respir Med
Main Authors: Cao, Mengshu, Wamboldt, Frederick S., Brown, Kevin K., Hickman, Jonathon, Olson, Amy L., Solomon, Joshua J., Swigris, Jeffrey J.
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4676151/
https://ncbi.nlm.nih.gov/pubmed/26693009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40248-015-0035-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items